DBV Technologies DBVT
NASDAQ DBVT
$11.88 +0.37 (+3.21%)
At close: Nov 11, 2026 · 4:00 PM EST

DBV Technologies (DBVT) Gross Margin (2015)

Updated

DBV Technologies (DBVT) posted Gross Margin of 36.63% for FY2015.

Analysis

DBV Technologies (DBVT) Gross Margin (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 DBV Technologies 1.04 Bn 274.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 14.81%
API Access

DBV Technologies Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=DBVT&period=max&api_key=YOUR_API_KEY